Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

A Phase II Trial to Compare Allogeneic Transplant Vs. Standard of Care for Severe Sickle Cell Disease: Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Protocol 1503

Mary Eapen, MBBS, MS, Donna S Neuberg, ScD, Adam M. Mendizabal, MS, Kristen E. Stevenson, MS, Joseph H. Antin, MD, Nancy DiFronzo, PhD, Fuad A El Rassi, MD, Premal Lulla, MBBS, Edmund K. Waller, PhDMD, Jamie Garrison, Shannon Smith, MSN, Keith Sullivan, MD, Mark C. Walters, MD, Lakshmanan Krishnamurti, MD

Blood (2019) 134 (Supplement_1): 4592.

https://doi.org/10.1182/blood-2019-126793

Published: 2019

Journal Articles

Pre-Transplant Hepatic Steatosis (fatty liver) Predicts Chronic Graft-Vs-Host Disease but Does Not Affect Mortality

Ko Ko Ko Maung, MD, Mohammad Chaudhry, MD, Yi Ren, MS, Sin-Ho Jung, PhD, Kristi M. Romero, BS, Kelly Corbet, BS, Nelson J. Chao, MD, Taewoong Choi, MD, Anna Mae Diehl, MD, Louis F. Diehl, MD, Cristina Gasparetto, MD, Mitchell E. Horwitz, MD, Gwynn D. Long, MD, Richard D. Lopez, MD, David A. Rizzieri, MD, Stefanie Sarantopoulos, MD PhD, Keith Sullivan, MD, Mustafa R. Bashir, MD, Anthony D. Sung, MD

Blood (2019) 134 (Supplement_1): 5731.

https://doi.org/10.1182/blood-2019-121830

Published: 2019

Journal Articles

Total Body Irradiation 1350cGy/Fludarabine (TBI/FLU) vs Myeloablative Busulfan/Fludarabine (Bu/Flu) Preparation in Adult Recipients of Dual Umbilical Cord Blood (UCB) Transplantation: Superior Engraftment with Low Treatment-Related Mortality

Mitchell Horwitz, MD, John Chute, MD, Cristina Gasparetto, MD, Gwynn Long, MD, David Rizzieri, MD, Keith Sullivan, MD, Jackie McPherson, Nelson Chao, MD

Blood (2008) 112 (11): 4403.

https://doi.org/10.1182/blood.V112.11.4403.4403

Published: 2008

Journal Articles

Myeloablative Intravenous Busulfan/Fludarabine Conditioning Does Not Facilitate Reliable Engraftment of Dual Umbilical Cord Blood Grafts in Adult Recipients.

Mitchell Horwitz, MD, John Chute, MD, Cristina Gasparetto, MD, Gwynn Long, MD, David Rizzieri, MD, Ashley Morris, PharmD, Jackie McPherson, Keith Sullivan, MD, Nelson Chao, MD

Blood (2007) 110 (11): 2007.

https://doi.org/10.1182/blood.V110.11.2007.2007

Published: 2007

Journal Articles

Adult Umbilical Cord Blood Transplantation Following Non-Myeloablative Conditioning; Impact of Increased Cell Dose and 200cGy TBI on Engraftment and Survival.

Mitchell Horwitz, MD, David Rizzieri, MD, Gwynn D. Long, MD, Cristina Gasparetto, MD, Ashley Morris, PharmD, Keith Sullivan, MD, John Chute, MD, Dawn Marshall, Nelson Chao, MD

Blood (2006) 108 (11): 5399.

https://doi.org/10.1182/blood.V108.11.5399.5399

Published: 2006

Journal Articles

Four-Year Follow-Up after High-Dose Immunosuppressive Therapy (HDIT) for Severe Systemic Sclerosis (SSc).

Richard A. Nash, Peter McSweeney, Leslie Crofford, Kevin T. McDonagh, Maureen Mayes, J. Lee Nelson, Ted Gooley, Leona Holmberg, Howard Shulman, Mark Wener, Bernadette McLaughlin, Gretchen Henstorf, Jerry Molitor, James Seibold, Keith Sullivan, Daniel Furst

Blood (2006) 108 (11): 3071.

https://doi.org/10.1182/blood.V108.11.3071.3071

Published: 2006

Journal Articles

High-Dose Immunosuppressive Therapy (HDIT) for Severe Systemic Sclerosis (SSc): Long-Term Survivors Show Continued Improvement of Function and Skin with Stability in the Lungs.

Peter McSweeney, MD, Daniel Furst, MD, Leslie Crofford, MD, Kevin McDonagh, MD, Keith Sullivan, MD, Mayes Maureen, MD, Nelson Lee, MD, Theodore Gooley, Ph.D., Jan Storek, MD, PhD, Leona Holmberg, MD, PhD, C.S. Chen, MD, PhD, Mark Wener, MD, Julie Lee, RN, Gretchen Henstorf, CCRC, Muneer Abidi, MD, Philip Mease, MD, Richard Nash, MD

Blood (2004) 104 (11): 149.

https://doi.org/10.1182/blood.V104.11.149.149

Published: 2004

NARROW

A Phase II Trial to Compare Allogeneic Transplant Vs. Standard of Care for Severe Sickle Cell Disease: Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Protocol 1503

Pre-Transplant Hepatic Steatosis (fatty liver) Predicts Chronic Graft-Vs-Host Disease but Does Not Affect Mortality

Total Body Irradiation 1350cGy/Fludarabine (TBI/FLU) vs Myeloablative Busulfan/Fludarabine (Bu/Flu) Preparation in Adult Recipients of Dual Umbilical Cord Blood (UCB) Transplantation: Superior Engraftment with Low Treatment-Related Mortality

Myeloablative Intravenous Busulfan/Fludarabine Conditioning Does Not Facilitate Reliable Engraftment of Dual Umbilical Cord Blood Grafts in Adult Recipients.

Adult Umbilical Cord Blood Transplantation Following Non-Myeloablative Conditioning; Impact of Increased Cell Dose and 200cGy TBI on Engraftment and Survival.

Four-Year Follow-Up after High-Dose Immunosuppressive Therapy (HDIT) for Severe Systemic Sclerosis (SSc).

High-Dose Immunosuppressive Therapy (HDIT) for Severe Systemic Sclerosis (SSc): Long-Term Survivors Show Continued Improvement of Function and Skin with Stability in the Lungs.

Email alerts

ASH Publications

American Society of Hematology

A Phase II Trial to Compare Allogeneic Transplant Vs. Standard of Care for Severe Sickle Cell Disease: Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Protocol 1503

Pre-Transplant Hepatic Steatosis (fatty liver) Predicts Chronic Graft-Vs-Host Disease but Does Not Affect Mortality

Total Body Irradiation 1350cGy/Fludarabine (TBI/FLU) vs Myeloablative Busulfan/Fludarabine (Bu/Flu) Preparation in Adult Recipients of Dual Umbilical Cord Blood (UCB) Transplantation: Superior Engraftment with Low Treatment-Related Mortality

Myeloablative Intravenous Busulfan/Fludarabine Conditioning Does Not Facilitate Reliable Engraftment of Dual Umbilical Cord Blood Grafts in Adult Recipients.

Adult Umbilical Cord Blood Transplantation Following Non-Myeloablative Conditioning; Impact of Increased Cell Dose and 200cGy TBI on Engraftment and Survival.

Four-Year Follow-Up after High-Dose Immunosuppressive Therapy (HDIT) for Severe Systemic Sclerosis (SSc).

High-Dose Immunosuppressive Therapy (HDIT) for Severe Systemic Sclerosis (SSc): Long-Term Survivors Show Continued Improvement of Function and Skin with Stability in the Lungs.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only